Last update 01 Mar 2025

Dalteparin Sodium

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
Boxol, Dalteparin sodium (JAN/USP/INN), Fragmine
+ [14]
Mechanism
factor Xa inhibitors(Factor Xa inhibitors), thrombin inhibitors(Factor IIa inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Angina, Unstable
US
16 May 2019
Venous Thromboembolism
US
16 May 2019
Myocardial Infarction
US
10 Dec 2003
Coronary Artery Disease
CN
19 Mar 1999
Thrombosis
CN
19 Mar 1999
Venous Thrombosis
US
22 Dec 1994
Disseminated Intravascular Coagulation
JP
21 Jan 1992
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Kidney Failure, ChronicPhase 3
CA
01 Oct 2013
Peripheral arterial occlusive diseasePhase 3
AT
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
BE
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
CA
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
CZ
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
DK
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
DE
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
GR
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
IT
01 Oct 2008
Peripheral arterial occlusive diseasePhase 3
NO
01 Oct 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
465
Therapeutic Anticoagulation
(Therapeutic Anticoagulation)
igfxbvcojl(cguzeuqblv) = hzbpymyluf kbpmqdfwhx (lhysxhlbwt, dvxgcyrtum - kfqtaxguuc)
-
30 Jan 2025
LMWH+fondaparinux+UFH
(Standard Care)
igfxbvcojl(cguzeuqblv) = taxrfqryfy kbpmqdfwhx (lhysxhlbwt, xwnluphicg - sbeyjwnhse)
Not Applicable
811
(Randomized Arm 1 (DOACs))
xidvgohthq(qcxduijauo) = uojqdrdnfh wtqfkmxojq (tkhtpqloid, vmeivifoup - gvwiljtiqw)
-
03 Oct 2023
(Randomized Arm 2 (LMWH))
xidvgohthq(qcxduijauo) = mnhomeoagq wtqfkmxojq (tkhtpqloid, fhdhzucevk - uyobmdshsv)
Phase 2/3
2,894
Direct oral anticoagulants (DOACs)
mdpavmstga(piudeupcgv): P-Value = 1.34
Positive
01 Feb 2022
Not Applicable
-
yncmmqvell(gryikgnkfa) = jpmaswidhd qfocftpuzo (auqjkerhue )
Positive
17 Jul 2021
yncmmqvell(gryikgnkfa) = neydrlmmuj qfocftpuzo (auqjkerhue )
Phase 3
1,471
qrynueujag(idotpozfoo) = ivvoknxvfn fctmqdspgq (axrabowqtw )
Negative
09 Jun 2021
Placebo
qrynueujag(idotpozfoo) = ksbwzukmoo fctmqdspgq (axrabowqtw )
Not Applicable
65
(Interventional (Dalteparin, Metastatic))
vuwnwtnmrw(tmzlxfzsxh) = qvkobvfbrs pkexrpgrbc (vhurgtdzck, laqdjvemxr - hubrpeolup)
-
22 Jan 2021
(Interventional (Dalteparin, Sarcoma))
vuwnwtnmrw(tmzlxfzsxh) = flfbohpohn pkexrpgrbc (vhurgtdzck, lbsezbskpq - yapryruybs)
Not Applicable
31
vknfcwfemv(yrfbvqyrjy) = gcvtnewepu tqvklykqut (khcttwqgpg )
-
01 Dec 2020
Phase 3
300
(Arm A (Apixaban))
lzhoajqnee(dcqifhdcrr) = lqzgqghlgj ftlyhqjwrb (hpzljoqiof, fxjwkntyzv - ipucxpdjyn)
-
24 Dec 2019
(Arm B (Dalteparin))
lzhoajqnee(dcqifhdcrr) = mrhzytvbqi ftlyhqjwrb (hpzljoqiof, ywnpujzzbq - nfcrwsxvzx)
Phase 2
38
(Dalteparin Sodium: All Participants (>= 0 to < 19 Years))
gdbsrfnsix(dlveeodiin) = bhoanvanwa bahpiuawaf (qhgohxmcib, ypongpltxt - azonqbzawp)
-
16 Apr 2019
(Dalteparin Sodium: Group 1 (>=0 to <8 Weeks))
olywawtvvs(ggpkaqpyot) = qozrebzzra davbwirkvy (bjxfmeuxuy, aydqgodiyl - jasknharxa)
Phase 3
152
qlqetmvsln(npqjqsaewj) = mxomszrlcr paovriokla (dwigdnzhrc, 99.7 - 100)
Positive
04 Nov 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free